Artículos por temáticas

More than ataxia - Movement disorders in ataxia-telangiectasia.

Teive HAG, Camargo CHF, Munhoz RP.

Parkinsonism Relat Disord. 2018 Jan;46:3-8. doi: 10.1016/j.parkreldis.2017.12.009. Epub 2017 Dec 12. Review.

[The role of laryngeal electromyography in the diagnosis of vocal cord movement disorders].

Bach Á, Sztanó B, Kiss JG, Volk GF, Müller A, Pototschnig C, Rovó L.

Orv Hetil. 2018 Feb;159(8):303-311. doi: 10.1556/650.2018.30975. Hungarian.

Male and female opinions about orthotic devices of the lower limb: A multicentre, observational study in patients with central neurological movement disorders.

Swinnen E, Lefeber N, Werbrouck A, Gesthuizen Y, Ceulemans L, Christiaens S, De Wael L, Buyl R, Ilsbroukx S, Van Nieuwenhoven J, Michielsen M, Lafosse C, Kerckhofs E.

NeuroRehabilitation. 2018;42(1):121-130. doi: 10.3233/NRE-172214.

Medical Management of Movement Disorders.

Picillo M, Munhoz RP.

Prog Neurol Surg. 2018;33:41-49. doi: 10.1159/000480747. Epub 2018 Jan 12.

Botulinum neurotoxin for the treatment of movement disorders.

Kopanidis P, Das C.

Aust J Gen Pract. 2018 Sep;47(9):598-601.

Index Finger Pointing (Likely a Subtle Form of Hand Dystonia): Prevalence Across Movement Disorders.

Vives-Rodriguez A, Louis ED.

Front Neurol. 2018 Jul 4;9:542. doi: 10.3389/fneur.2018.00542. eCollection 2018.

Movement disorders in cerebrotendinous xanthomatosis.

Stelten BML, van de Warrenburg BPC, Wevers RA, Verrips A.

Parkinsonism Relat Disord. 2018 Jul 19. pii: S1353-8020(18)30310-9. doi: 10.1016/j.parkreldis.2018.07.006. [Epub ahead of print] Review.

Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review.

Vaz RL, Outeiro TF, Ferreira JJ.

Front Neurol. 2018 Jun 1;9:347. doi: 10.3389/fneur.2018.00347. eCollection 2018.

The Role of a Neuropsychologist on a Movement Disorders Deep Brain Stimulation Team.

Kubu CS.

Arch Clin Neuropsychol. 2018 May 1;33(3):365-374. doi: 10.1093/arclin/acx130.

Pediatric NMDAR encephalitis: A single center observation study with a closer look at movement disorders.

Granata T, Matricardi S, Ragona F, Freri E, Zibordi F, Andreetta F, Binelli S, Nardocci N.

Eur J Paediatr Neurol. 2018 Mar;22(2):301-307. doi: 10.1016/j.ejpn.2018.01.012. Epub 2018 Feb 1.

Rechargeable Internal Pulse Generators as Initial Neurostimulators for Deep Brain Stimulation in Patients With Movement Disorders.

Jakobs M, Kloß M, Unterberg A, Kiening K.

Neuromodulation. 2018 Jan 8. doi: 10.1111/ner.12748. [Epub ahead of print]

Functional movement disorders of the face: A historical review and case series.

Stone J, Hoeritzauer I, Tesolin L, Carson A.

J Neurol Sci. 2018 Dec 15;395:35-40. doi: 10.1016/j.jns.2018.09.031. Epub 2018 Sep 26.

Movement Disorders and Deep Brain Stimulation in the Middle East.

Siddiqui JH, Bhatti D, Alsubaie F, Bajwa JA.

World Neurosurg. 2018 Feb 13. pii: S1878-8750(18)30293-6. doi: 10.1016/j.wneu.2018.02.023. [Epub ahead of print] No abstract available.

Drug Delivery for Movement Disorders.

Barua N, Gill S.

Prog Neurol Surg. 2018;33:243-252. doi: 10.1159/000481108. Epub 2018 Jan 12.

Treatment of psychiatric disturbances in common hyperkinetic movement disorders.

Berardelli I, Pasquini M, Conte A, Bologna M, Berardelli A, Fabbrini G.

Expert Rev Neurother. 2018 Dec 1. doi: 10.1080/14737175.2019.1555475. [Epub ahead of print]